<table> 

<tr><td>ex Chapter 30</td>
<td>Pharmaceutical products; except for:</td>
<td>Manufacture from materials of any heading, except that of the product. However, materials of the same heading as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td>3002</td>
<td>Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:</td>
<td></td>
<td></td></tr>
<tr><td></td>
<td>- Products consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses or unmixed products for these uses, put up in measured doses or in forms or packings for retail sale</td>
<td>Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td></td>
<td>- Other</td>
<td></td>
<td></td></tr>
<tr><td></td>
<td>- - Human blood</td>
<td>Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td></td>
<td>- - Animal blood prepared for therapeutic or prophylactic uses</td>
<td>Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td></td>
<td>- - Blood fractions other than antisera, haemoglobin, blood globulins and serum globulins</td>
<td>Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td></td>
<td>- - Haemoglobin, blood globulins and serum globulins</td>
<td>Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td></td>
<td>- - Other</td>
<td>Manufacture from materials of any heading, including other materials of heading 3002. However, materials of the same description as the product may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td>3003 and 3004</td>
<td>Medicaments (excluding goods of heading 3002, 3005 or 3006):</td>
<td></td>
<td></td></tr>
<tr><td></td>
<td>- Obtained from amikacin of heading 2941</td>
<td>Manufacture from materials of any heading, except that of the product. However, materials of headings 3003 or 3004 may be used, provided that their total value does not exceed 20% of the ex-works price of the product</td>
<td></td></tr>
<tr><td></td>
<td>- Other</td>
<td>Manufacture <br />- from materials of any heading, except that of the product. However, materials of headings 3003 or 3004 may be used, provided that their total value does not exceed 20% of the ex-works price of the product, and <br />- in which the value of all the materials used does not exceed 50% of the ex-works price of the product</td>
<td>
</tr>
<tr><td>ex30 06</td>
<td>Waste pharmaceuticals specified in note 4(k) to this chapter</td>
<td>The origin of the product in its original classification shall be retained</td>
<td></td></tr>
<tr><td>
</table>
